---
title: "The \"safest\" A-share strategy for next week is still this one!"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/234708811.md"
description: "Next week, the A-share market will welcome a new round of trading, with investors focusing on how to control portfolio volatility. The subscription for new stocks has become the focal point, with multiple new stocks recently listed. SOFARSOLAR's market value exceeded 17 billion yuan after its listing, despite the company's forecast of a significant decline in operating revenue and net profit in 2024. Next week, two new stocks will be open for subscription, namely Kente and ONGOAL, the latter being the first company this year to receive IPO approval"
datetime: "2025-04-07T02:16:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/234708811.md)
  - [en](https://longbridge.com/en/news/234708811.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/234708811.md)
---

# The "safest" A-share strategy for next week is still this one!

After experiencing a series of news and announcements during the Qingming Festival holiday, the A-share market is about to embark on a new round of "battles" next week.

In the face of the changing global trade environment, how to control the volatility of one's own portfolio has become a topic of contemplation for many investors during the holiday.

The prominence of new stock subscriptions has become evident at this time.

In the past month, multiple new stocks have been listed each week, and the highest profit from a single subscription at the beginning of the year has been continuously refreshed. Even in the relatively quiet week just passed, the only listed stock on the ChiNext achieved a profit of 13,340 yuan from a single subscription.

In the coming week (April 7 - April 11), two new stocks will be open for subscription. On April 7 (Monday), Kente, which plans to list on the Shanghai Stock Exchange, and on April 8 (Tuesday), ONGOAL will be listed on the ChiNext.

## Profit of 13,340 Yuan from a Single Subscription

On April 2, SOFARSOLAR was listed on the ChiNext with an issue price of 11.80 yuan per share. The final closing price was 40.65 yuan per share, an increase of 226.12%, allowing a profit of 13,340 yuan from a single subscription.

Although this figure is not as attractive as in previous weeks, it still continues the profitability of the new stock subscription strategy.

In terms of the subscription rate, SOFARSOLAR was not particularly high, at 0.021877%.

SOFARSOLAR is a "small giant" company in the photovoltaic industry, primarily engaged in the research, development, production, sales, and service of new energy power equipment.

However, like other companies in the same industry, SOFARSOLAR has also experienced rapid growth after the explosion of overseas markets and challenges following a decline in demand over the past few years.

The company predicts that its operating revenue in 2024 will be approximately 2.713 billion yuan, a year-on-year decrease of 27.53%, and a drop of about 40% compared to the peak of approximately 4.457 billion yuan in 2022. The net profit attributable to the parent company in 2024 is expected to be 255 million yuan, a year-on-year decrease of 25.25%, and a drop of about 70% compared to 849 million yuan in 2022.

However, this has clearly not significantly affected SOFARSOLAR's performance, as the company's market capitalization decisively exceeded 17 billion yuan after its listing before the holiday.

## The First Registration Approval of 2025

The ONGOAL, which will open for subscription next Tuesday, actually received the first IPO approval of the year on January 2 this year.

This is a company focused on the research, development, production, and sales of automated processing production lines and equipment for bulk materials such as powder, granules, liquids, and pastes, and has won the "CATL 2022 Technology Innovation Award."

Currently, most of the company's revenue comes from the downstream lithium battery industry. According to downstream industry classification, from 2021 to 2023 and from January to September 2024, the proportion of revenue from the lithium battery industry in the company's main business income was 71.99%, 90.85%, 92.18%, and 87.37%, respectively.

The prospectus indicates that the risk of structural overcapacity in power battery production is accumulating, which also poses a risk of overcapacity for the company. However, a significant portion of the funds raised by ONGOAL will still be used for capacity expansion 
Previously, the exchange required ONGOAL to explain the necessity and rationality of the main fundraising for construction projects, land acquisition, and equipment investment, considering the company's scale, market environment, and R&D level, as well as whether the newly built houses would be used for rental or sale, and whether it involves real estate business.

Since 2024, the company's downstream expansion pace has slowed down, with significant declines in both operating revenue and net profit. From January to September 2024, the operating revenue and net profit were approximately CNY 1.459 billion and CNY 111 million, respectively, down 26.44% and 37.42% year-on-year.

From 2021 to 2023, the company's operating revenue was approximately CNY 579 million, CNY 2.178 billion, and CNY 3.198 billion, with net profits of approximately CNY 50 million, CNY 298 million, and CNY 315 million.

## Kente's Gross Profit Rises Against the Trend

Another company opening new stock subscriptions, Kente, mainly engages in the R&D, production, and sales of quaternary ammonium (quaternary) compound products, currently offering four major product series: quaternary ammonium salts, quaternary ammonium bases, quaternary ammonium salts, and crown ethers.

The company's main customers are concentrated in the molecular sieve and battery electrolyte fields, accumulating enterprise clients such as Zhongchuan Catalyst, Huahai Pharmaceutical, and Wanhua Chemical in the fields of molecular sieves, pharmaceuticals, and petrochemicals, and entering the supply chains of well-known companies in the battery electrolyte field such as Yongtai Technology and New Chemical.

It is worth emphasizing that while the average gross profit margin in the industry continues to decline, Kente's gross profit margin slightly increased in the first half of 2024.

From 2021 to 2023 and in the first half of 2024, Kente's gross profit margins were 27.71%, 26.48%, 26.23%, and 27.04%, respectively.

In terms of operating revenue, the company predicts that the total operating revenue for 2024 will be approximately CNY 617 million, with a net profit of approximately CNY 93.51 million, representing a year-on-year decline of 7.40% and an increase of 9.75%, respectively. Although the operating revenue is even lower than the level in 2021, profitability has rebounded to some extent.

From 2021 to 2023, Kente's operating revenue was approximately CNY 636 million, CNY 808 million, and CNY 666 million, with net profits of approximately CNY 86.34 million, CNY 109.59 million, and CNY 85.21 million.

Risk Warning and Disclaimer

The market has risks, and investment requires caution. This article does not constitute personal investment advice and does not take into account the specific investment goals, financial conditions, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article align with their specific circumstances. Investment based on this is at their own risk

### Related Stocks

- [301658.CN](https://longbridge.com/en/quote/301658.CN.md)
- [301662.CN](https://longbridge.com/en/quote/301662.CN.md)
- [603120.CN](https://longbridge.com/en/quote/603120.CN.md)
- [300037.CN](https://longbridge.com/en/quote/300037.CN.md)
- [688267.CN](https://longbridge.com/en/quote/688267.CN.md)
- [300750.CN](https://longbridge.com/en/quote/300750.CN.md)
- [002326.CN](https://longbridge.com/en/quote/002326.CN.md)
- [600309.CN](https://longbridge.com/en/quote/600309.CN.md)
- [00386.HK](https://longbridge.com/en/quote/00386.HK.md)
- [600521.CN](https://longbridge.com/en/quote/600521.CN.md)
- [CP00043.US](https://longbridge.com/en/quote/CP00043.US.md)